PortfoliosLab logoPortfoliosLab logo
ISIN
US4523271090
CUSIP
452327109
IPO Date
Jul 28, 2000

Highlights

Market Cap
$25.03B
Enterprise Value
$26.91B
EPS (TTM)
$5.48
PE Ratio
29.68
PEG Ratio
14.26
Total Revenue (TTM)
$4.39B
Gross Profit (TTM)
$2.93B
EBITDA (TTM)
$1.39B
Year Range
$81.76 - $165.97
Target Price
$147.13
ROA (TTM)
13.01%
ROE (TTM)
28.17%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

ILMN Performance Chart

Illumina, Inc. (ILMN) is up 23.9% since the beginning of the year. At $163 per share, ILMN is trading just below its 52-week high of $166. Investors who bought $1,000 worth of ILMN shares 5 years ago would now be looking at an investment worth $413.


Loading charts...

S&P 500 Index

Returns By Period

Illumina, Inc. (ILMN) has returned 23.93% so far this year and 100.46% over the past 12 months. Over the last ten years, ILMN has returned 1.39% per year, falling short of the S&P 500 Index benchmark, which averaged 13.75% annually.


Illumina, Inc.

1D
-1.13%
1M
19.72%
YTD
23.93%
6M
27.44%
1Y
100.46%
3Y*
-6.93%
5Y*
-16.21%
10Y*
1.39%

Benchmark (S&P 500 Index)

1D
0.13%
1M
5.25%
YTD
11.16%
6M
11.43%
1Y
28.20%
3Y*
21.12%
5Y*
12.66%
10Y*
13.75%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ILMN Monthly Returns History

Based on dividend-adjusted daily data since Jul 28, 2000, ILMN's average daily return is +0.10%, while the average monthly return is +1.91%. At this rate, an investment would double in approximately 3.1 years.

Historically, 57% of months were positive and 43% were negative. The best month was May 2003 with a return of +73.4%, while the worst month was Mar 2001 at -52.9%. The longest winning streak lasted 16 consecutive months, and the longest losing streak was 5 months.

On a daily basis, ILMN closed higher 51% of trading days. The best single day was Jan 25, 2012 with a return of +46.3%, while the worst single day was Oct 7, 2011 at -31.9%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202610.41%-7.15%-8.33%2.82%28.58%-0.25%23.93%
2025-0.67%-33.15%-10.59%-2.19%5.98%16.01%7.65%-2.68%-4.99%30.08%6.40%-0.22%-1.85%
20242.71%-2.22%-1.80%-10.39%-15.25%2.90%17.46%7.18%-0.75%10.53%0.01%-7.30%-1.34%
20235.93%-7.00%16.74%-11.61%-4.33%-4.66%2.49%-14.02%-16.91%-20.29%-6.83%36.58%-31.14%
2022-8.31%-6.37%6.98%-15.10%-19.27%-23.02%17.53%-6.94%-5.38%19.93%-4.69%-7.28%-46.85%
202115.25%3.04%-12.60%2.29%3.26%16.66%4.76%-7.78%-11.28%2.33%-11.98%4.14%2.82%

Benchmark Metrics

Illumina, Inc. has an annualized alpha of 15.72%, beta of 1.14, and R2 of 0.15 versus S&P 500 Index. Calculated based on daily prices since July 31, 2000.

  • This stock captured 193.84% of S&P 500 Index gains and 154.29% of its losses - amplifying both gains and losses, but participating more in upside than downside.
  • R2 of 0.15 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
15.72%
Beta
1.14
0.15
Upside Capture
193.84%
Downside Capture
154.29%

Return for Risk

Risk / Return Rank

ILMN ranks 87 for risk / return — in the top 87% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.


ILMN Risk / Return Rank: 8787
Overall Rank
ILMN Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
ILMN Sortino Ratio Rank: 8888
Sortino Ratio Rank
ILMN Omega Ratio Rank: 8686
Omega Ratio Rank
ILMN Calmar Ratio Rank: 8787
Calmar Ratio Rank
ILMN Martin Ratio Rank: 8585
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Illumina, Inc. (ILMN) and compare them to S&P 500 Index.


ILMNBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

2.16

2.39

-0.22

Sortino ratio

Return per unit of downside risk

3.10

3.25

-0.15

Omega ratio

Gain probability vs. loss probability

1.38

1.43

-0.06

Calmar ratio

Return relative to maximum drawdown

3.94

3.11

+0.82

Martin ratio

Return relative to average drawdown

8.92

14.38

-5.46

Dividends

Dividend History


Illumina, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Illumina, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Illumina, Inc. was 96.14%, occurring on Mar 13, 2003. Recovery took 1100 trading sessions.

The current Illumina, Inc. drawdown is 68.16%.


Related event

Drawdown

Fall

Recovery

Underwater

2003 bear market2003
-96.14%Mar 2003
2y 6mo4y 4mo
6y 10moSep 2000 - Jul 2007
2025 selloff2025
-86.23%Apr 2025
3y 7mo
4y 9moAug 2021 - now
2011 bear market2011
-66.67%Dec 2011
5mo 9d1y 7mo
2y 18dJul 2011 - Jul 2013
Financial crisis2007–2009
-57.85%Nov 2008
3mo 5d1y 8mo
1y 11moAug 2008 - Aug 2010
2016 bear market2016
-49.16%Dec 2016
1y 4mo1y 1mo
2y 5moJul 2015 - Jan 2018

Drawdown Indicators


ILMNBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-96.14%

-56.78%

-39.36%

Max Drawdown (1Y)

Largest decline over 1 year

-25.66%

-9.10%

-16.56%

Max Drawdown (3Y)

Largest decline over 3 years

-65.68%

-18.90%

-46.78%

Max Drawdown (5Y)

Largest decline over 5 years

-86.23%

-25.43%

-60.80%

Max Drawdown (10Y)

Largest decline over 10 years

-86.23%

-33.92%

-52.31%

Current Drawdown

Current decline from peak

-68.16%

0.00%

-68.16%

Average Drawdown

Average peak-to-trough decline

-40.37%

-10.72%

-29.65%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.30%

1.97%

+9.33%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Illumina, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Illumina, Inc. is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for ILMN, comparing it with other companies in the Diagnostics & Research industry. Currently, ILMN has a P/E ratio of 29.7. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for ILMN compared to other companies in the Diagnostics & Research industry. ILMN currently has a PEG ratio of 14.3. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ILMN relative to other companies in the Diagnostics & Research industry. Currently, ILMN has a P/S ratio of 5.8. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ILMN in comparison with other companies in the Diagnostics & Research industry. Currently, ILMN has a P/B value of 8.3. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with ILMN

Add Illumina, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with ILMN